Trexquant Investment’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,385
Closed -$64.9K 1900
2023
Q1
$64.9K Buy
+10,385
New +$64.9K ﹤0.01% 1390
2022
Q4
Sell
-24,117
Closed -$288K 1816
2022
Q3
$288K Buy
24,117
+10,697
+80% +$128K 0.01% 1050
2022
Q2
$169K Buy
+13,420
New +$169K 0.01% 1389